Table 2 |
||||
|
Over represented KEGG pathways using Illumina sequencing. |
||||
|
Term |
Count |
Pop Hits |
PValue |
Benjamini |
|
|
||||
|
hsa04610:Complement and coagulation cascades |
60 |
68 |
3.08E-08 |
7.11E-06 |
|
hsa04910:Insulin signaling pathway |
96 |
133 |
1.06E-04 |
0.0122 |
|
hsa00020:Citrate cycle (TCA cycle) |
25 |
27 |
2.23E-04 |
0.0170 |
|
hsa00120:Bile acid biosynthesis |
31 |
36 |
4.23E-04 |
0.0242 |
|
hsa00071:Fatty acid metabolism |
37 |
45 |
5.35E-04 |
0.0244 |
|
hsa00980:Metabolism of xenobiotics by cytochrome P450 |
50 |
65 |
7.29E-04 |
0.0277 |
|
hsa00190:Oxidative phosphorylation |
85 |
121 |
0.001155 |
0.0374 |
|
hsa00310:Lysine degradation |
38 |
48 |
0.001627 |
0.0459 |
|
hsa04510:Focal adhesion |
128 |
196 |
0.004824 |
0.0966 |
|
|
||||
|
hsa00051:Fructose and mannose metabolism |
33 |
42 |
0.00463 |
0.102 |
|
hsa00650:Butanoate metabolism |
35 |
45 |
0.00448 |
0.109 |
|
hsa04520:Adherens junction |
52 |
74 |
0.0129 |
0.171 |
|
hsa04810:Regulation of actin cytoskeleton |
133 |
208 |
0.0116 |
0.175 |
|
hsa04912:GnRH signaling pathway |
64 |
93 |
0.0109 |
0.177 |
|
hsa00010:Glycolysis/Gluconeogenesis |
43 |
59 |
0.0110 |
0.177 |
|
hsa00230:Purine metabolism |
94 |
143 |
0.0128 |
0.180 |
|
hsa00280:Valine, leucine and isoleucine degradation |
33 |
44 |
0.0147 |
0.183 |
|
hsa05010:Alzheimer's disease |
23 |
29 |
0.0200 |
0.228 |
|
hsa00620:Pyruvate metabolism |
31 |
42 |
0.0262 |
0.253 |
|
hsa05210:Colorectal cancer |
57 |
84 |
0.0250 |
0.254 |
|
hsa00260:Glycine, serine and threonine metabolism |
33 |
45 |
0.0241 |
0.256 |
|
hsa04514:Cell adhesion molecules (CAMs) |
82 |
126 |
0.0285 |
0.262 |
|
hsa04670:Leukocyte transendothelial migration |
74 |
113 |
0.0315 |
0.275 |
|
hsa00220:Urea cycle and metabolism of amino groups |
23 |
30 |
0.0359 |
0.297 |
|
hsa04360:Axon guidance |
81 |
126 |
0.0429 |
0.313 |
|
hsa04370:VEGF signaling pathway |
47 |
69 |
0.0401 |
0.315 |
|
hsa05120:Epithelial cell signaling in Helicobacter pylori infection |
47 |
69 |
0.0401 |
0.315 |
|
hsa00052:Galactose metabolism |
24 |
32 |
0.0448 |
0.315 |
|
hsa00480:Glutathione metabolism |
27 |
37 |
0.0495 |
0.315 |
|
hsa00903:Limonene and pinene degradation |
22 |
29 |
0.0488 |
0.319 |
|
hsa05040:Huntington's disease |
22 |
29 |
0.0488 |
0.319 |
|
hsa03320:PPAR signaling pathway |
47 |
70 |
0.0549 |
0.327 |
|
hsa00380:Tryptophan metabolism |
41 |
60 |
0.0535 |
0.328 |
|
hsa05211:Renal cell carcinoma |
45 |
67 |
0.0605 |
0.330 |
|
hsa00591:Linoleic acid metabolism |
23 |
31 |
0.0596 |
0.333 |
|
hsa01510:Neurodegenerative Diseases |
28 |
39 |
0.0585 |
0.336 |
|
hsa00410:beta-Alanine metabolism |
19 |
25 |
0.0717 |
0.356 |
|
hsa00363:Bisphenol A degradation |
12 |
14 |
0.0691 |
0.360 |
|
hsa00640:Propanoate metabolism |
24 |
33 |
0.0712 |
0.361 |
|
hsa00860:Porphyrin and chlorophyll metabolism |
27 |
38 |
0.0752 |
0.363 |
|
hsa00740:Riboflavin metabolism |
13 |
16 |
0.0932 |
0.424 |
|
sa00770:Pantothenate and CoA biosynthesis |
13 |
16 |
0.0932 |
0.424 |
|
hsa04530:Tight junction |
81 |
130 |
0.0991 |
0.429 |
|
|
||||
|
Categories in bold are not found to be over represented in the microarray data. |
||||
|
Oshlack and Wakefield Biology Direct 2009 4:14 doi:10.1186/1745-6150-4-14 |
||||
